Case series | How do I treat patients with RRMM after failure of BCMA-targeted therapies?
The Multiple Myeloma Hub spoke with Paul Richardson, Dana-Farber Cancer Institute, Boston, US. We asked, How do I treat patients with relapsed/refractory multiple myeloma after failure of BCMA-targeted therapy?